Capricor Therapeutics (CAPR) Announces 4 94M Share Offering at $4 66/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO, Sept. 29, 2023 Capricor Therapeutics , a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of.
By Chris Wack Capricor Therapeutics shares were down 41% to $3.44 Friday after the company entered into definitive agreements with commercial partner Nippon.
Shares Capricor Therapeutics, Inc. (CAPR) are falling over 40% on Friday after the company announced that it has entered into an agreement with its commercial partner, Nippon Shinyaku, and funds associated with Highbridge Capital Management, for a registered direct offering of 4,935,621 shares of its common stock, for gross proceeds of approximately $23 million.